Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is 119 Page market research report with 115 Figures and 2 Tables published by Renub Research. All the 9 countries in the report have been studied from 3 viewpoints.
Cervical Cancer Test Market, Population & Mortality
1. Cervical Cancer Test Population (2008-2020)
Pap Smear Test Population & Forecast
HPV DNA Test Population & Forecast
2. Cervical Cancer Mortality Population (2001-2011)
3. Cervical Cancer Test Market (2008-2020)
Pap Smear Test Market & Forecast
HPV DNA Test Market & Forecast
9 Countries studied in the report are as follows
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.
Contact:
Ken Research
Ankur Gupta,
Head Marketing & Communications
+91-124- 4230204
